During the past decade, Dr.Deb Sanjay Nag conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr.Deb Sanjay Nag" are "Cognitive Dysfunction" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Dr.Deb Sanjay Nag" in a lesser frequency.

Most popular intervention types in "Dr.Deb Sanjay Nag" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine Injection" (1 trials) and "Repeat SARS-CoV-2 IgG antibodies at 45-65 days" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr.Deb Sanjay Nag" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr.Deb Sanjay Nag". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr.Deb Sanjay Nag, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr.Deb Sanjay Nag, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".